Picture of Orchid Pharma logo

ORCHPHARMA — Orchid Pharma News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Orchid Pharma gets Establishment Inspection Report from USFDA for Alathur API facility

April 11 (Reuters) - Orchid Pharma Ltd  ORCD.NS : 
 * Got establishment inspection report from USFDA based on successful inspection 
   closure for the API manufacturing facility at Alathur 
 
 * Source text: 
Orchid Pharma Ltd has informed BSE that Orchid received the Establishment inspection report (EIR) from USFDA based on the successful inspection closure for the API manufacturing facility located at Alathur, Kancheepuram District, India. The facility was inspected by USFDA in the month of August 2015. 
 
 
 * Further company coverage  ORCD.NS   
 ((Bengaluru Newsroom; +91 80 6749 1130))

Recent news on Orchid Pharma

See all news